Status
Conditions
Treatments
About
Post-marketing surveillance study to demonstrate the silent rupture rate and satisfaction of patients who underwent a primary and revision breast augmentation surgery with Motiva Implants®, 3 to 10 years before enrollment.
Full description
Single-arm, multicenter study with a minimum of 160 subjects who underwent Breast Implant surgery from 3-10 years postoperatively.
Following IRB / EC approval - and if applicable Competent Authority approval - Magnetic Resonance Imaging (MRI) and Patient-Reported Outcome (PRO) with the validated BREAST-Q will be collected at a single time point for all enrolled subjects.
MRI data will be used for the analysis of silent rupture, and BREAST-Q Postoperative Augmentation module scales to record patients for satisfaction.
Two styles of Motiva Implants® will be used for this study:
Henceforth, these devices will generally be referenced as "Motiva Implants®."
Enrollment
Sex
Volunteers
Inclusion criteria
Exclusion criteria
111 participants in 1 patient group
Loading...
Central trial contact
Ana Vega, MD; Sofia Chaves, PharmD
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal